By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301


SEARCH JOBS


Industry
Pharmaceutical






Company News
Innovus Pharma Signs Exclusive Marketing And Distribution Agreement With Danalife Aps To Market And Distribute Zestra® For Alternative Markets 8/28/2014 7:38:00 AM
Innovus Pharma Announces Formation Of A Global Clinical Advisory Board To Support The Growth Of Its Product Zestra® 8/21/2014 8:04:02 AM
Innovus Pharma And Consortia Health Initiate A Nationwide Marketing And Sales Campaign To U.S. Gynecologists For Zestra®, Clinically Proven For The Enhancement Of Female Arousal Desire And Satisfaction 8/15/2014 7:50:31 AM
Innovus Pharma Secures Additional Funding By Increasing Its Line Of Credit With Its Chief Executive Officer To $1.5 Million, Provides Quarter Update And Timing Of Its 10-Q Filing 8/6/2014 8:57:17 AM
Innovus Pharma To Present At The Fsxinterlinked Financial Investment Conference In Westlake Village, CA 7/29/2014 7:51:41 AM
Innovus Pharma To Exhibit Zestra®, Its Clinically Proven Topical Product For Sexual Arousal And Desire At The 46th Annual Meeting Of The American Association Of Sexuality Educators Counselors & Therapists 6/5/2014 9:05:53 AM
Innovus Pharma To Exhibit Zestra®, Its Clinically Proven Topical Product For Sexual Arousal And Desire At The 46th Annual Meeting Of The American Association Of Sexuality Educators Counselors & Therapists 6/4/2014 9:11:53 AM
Innovus Pharma Announces The Issuance Of A New Canadian Patent For Its Zestra® Product 5/19/2014 9:44:20 AM
Innovus Pharma Announces The Beginning Of Patient Enrollment In Its Post-Marketing Ejectdelay™ Clinical Study In The Middle East 5/15/2014 11:55:25 AM
Innovus Pharma Files For The Female Sexual Interest/Arousal Disorder (FSI/AD) Expanded Label Indication For Its Zestra® Product In Canada 5/13/2014 11:46:37 AM
123
//-->